Clinical Trial Update: Cryotherapy Combine Icotinib for Advanced NSCLC Treatment [Phase 4]

View source ↗

Summary

Phase 4 trial updating on combining cryotherapy with icotinib for advanced lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Neoplasms

Drugs mentioned

• Cryotherapy
• icotinib (icotinib)

Snippet

Sponsor: Fuda Cancer Hospital, Guangzhou | Conditions: Lung Neoplasms | Phase 4 | Status: COMPLETED